SCHEMBL6248402

SCHEMBL6248402

C=CCSc1ccccc1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.61
▸ POLB P06746 5/20 0.60
▸ RAB9A P51151 4/20 0.56
▸ LMNA P02545 2/20 0.54
▸ ICMT O60725 1/20 0.54
▸ GMNN O75496 1/20 0.54
▸ TRPA1 O75762 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ NFKB1 P19838 1/20 0.54
▸ CDK2 P24941 1/20 0.54
▸ RECQL P46063 1/20 0.54
▸ BLM P54132 1/20 0.54
▸ HIF1A Q16665 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ NPC1 O15118 3/20 0.49
▸ GAA P10253 1/20 0.49
▸ HSP90AA1 P07900 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL27474313 1.00 CYP1A2 (0.61) CYP1A2POLBRAB9ALMNAICMT
Phenylhydrazine SCHEMBL11784450 0.88 CYP1A2 (0.49) CYP1A2POLBRAB9ALMNAICMT
SCHEMBL8983732 0.87 CYP1A2 (0.44) CYP1A2POLBRAB9ALMNAICMT
SCHEMBL28877719 0.87 POLB (0.49) CYP1A2POLBRAB9ALMNAICMT
SCHEMBL7584830 0.85 RAB9A (0.47) CYP1A2POLBRAB9ALMNAICMT
SCHEMBL5832438 0.85 POLB (0.46) CYP1A2POLBRAB9ALMNAICMT
SCHEMBL11756536 0.84 CYP1A2 (0.42) CYP1A2POLBRAB9ALMNAICMT
SCHEMBL1399545 0.84 SIRT1 (0.50) CYP1A2POLBRAB9ALMNAICMT
SCHEMBL28857878 0.84 CYP1A2 (0.59) CYP1A2POLBRAB9ALMNAICMT
SCHEMBL13784467 0.84 POLB (0.46) CYP1A2POLBRAB9ALMNAICMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239111-B1 DRUG FOR TREATING BRAIN DISEASES, ENABLES PREVENTION OR TREATMENT OF DEMENTIA AND SIMILAR DISEASES CAUSED BY DEGENERATION OR SLOUGHING OF NEURONS, AN ALLY SULFIDE, SULFOXIDE OR SULFONE WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 — — US claimed
CN-109476616-B Piperazinyl methanone NAAA inhibitors 加利福尼亚大学董事会 2023-10-13 — — CN disclosed
CN-110769837-A Combination cancer immunotherapy with pentaazamacrocycle complexes 加莱拉实验室有限责任公司 2020-02-07 — — CN disclosed
CN-109476616-A Piperazinyl methanone NAAA inhibitor 加利福尼亚大学董事会 2019-03-15 — — CN disclosed
EP-3006429-B1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF SUMITOMO CHEMICAL CO (JP) 2019-02-06 — — EP disclosed
EP-2655337-B1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF SUMITOMO CHEMICAL CO (JP) 2016-11-23 — — EP disclosed
CN-103261170-B Fused heterocyclic compounds and their use for pest control 住友化学株式会社 2016-08-24 — — CN disclosed
EP-3006429-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF SUMITOMO CHEMICAL CO., LTD. (JP) 2016-04-13 — — EP disclosed
US-9278983-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-08 — — US disclosed
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-11 — — US disclosed
US-4299762-A ENZYMATIC DEACYLATION OF ANTIBIOTIC A TO PRODUCE ANTIFUNGAL AGENTS ELI LILLY AND COMPANY (US) 1981-11-10 — — US disclosed
US-4297277-A FUNGICIDES ANTISEPTICS ELI LILLY AND COMPANY (US) 1981-10-27 — — US disclosed
US-4293486-A ANTIFUNGAL PEPTIDES ELI LILLY AND COMPANY (US) 1981-10-06 — — US disclosed
US-4293484-A ANTIFUNGAL PEPTIDES ELI LILLY AND COMPANY (US) 1981-10-06 — — US disclosed
US-4293482-A PEPTIDE ANTIBIOTICS ELI LILLY AND COMPANY (US) 1981-10-06 — — US disclosed
US-4293489-A ANTIFUNGAL PEPTIDES ELI LILLY AND COMPANY (US) 1981-10-06 — — US disclosed
US-4293490-A PEPTIDE ANTIBIOTICS ELI LILLY AND COMPANY (US) 1981-10-06 — — US disclosed
US-4289692-A CYCLIC PEPTIDE ANTIBIOTICS ELI LILLY AND COMPANY (US) 1981-09-15 — — US disclosed
EP-0031220-A1 Derivatives of cyclic peptide nuclei ELI LILLY AND COMPANY (US) 1981-07-01 — — EP disclosed
US-4221800-A ANTIALLERGENS, ANTIHISTAMINES MILES LABORATORIES, INC. (US) 1980-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL NR4A1, NR2C2, NR0B1 CYP1A2 202/4885POLB 4737/4885RAB9A 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback